Mettler Toledo International Inc (MTD) Return on Investment ROI from the second quarter of 2026 to second quarter of 2024 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Mettler toledo International Inc   (NYSE: MTD)


Mettler Toledo International Inc's ROI from its second quarter of 2026 to the second quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Mettler Toledo International Inc's ROI in the second quarter of 2026?
Mettler toledo International Inc achieved a return on average invested assets (ROI) of 36.2 % in its second quarter of 2026, this is above MTD's average return on investment of 24.58%.
Mettler Toledo International Inc s investments during the 12 months ending in the second quarter of 2026 are valued at $2 billion

ROI has improved compared to 35.4% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 33 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 124 to 156.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 16.12 % 21.65 % 20.43 % 12.14 % 6.52 %
Y / Y Net Income Change TTM 9.14 % 3.04 % 26.77 % 92.86 % 274.08 %
Investment (TTM) in Millions 2,470 2,628 2,515 2,393 2,354
Return On Investment (TTM) 36.2 % 35.4 % 36.49 % 37.22 % 38.52 %
MTD's Overall Ranking # 156 # 124 # 23 # 72 # 108
Seq. Investment Change TTM 1.18 % 3.78 % 6.09 % 4.25 % 6 %
Seq. Net Income Change TTM 3.49 % 0.67 % 4 % 0.72 % -2.29 %
Net Income (TTM) in Millions 906 875 869 836 830

MTD Company Profile >> Back to MTD Roi Comparisons >> See Annual MTD Return On Investment



Return On Investment MTD's Ranking
Within: No.
Industry # 0
Sector # 34
Overall # 156

Return On Investment Statistics
High Average Low
41.47 %
24.58 %
1.77 %
(Dec 31 2024)  



  News about Mettler toledo International Inc Return on Investment ROI

Mettler Toledo's Long-Serving Board Chair Robert Spoerry to Retire, Prompting Evaluation of Financial Performance and Leadership Succession

December 14, 2023

Report: Mettler Toledo s Board Chair, Robert Spoerry, Announces Retirement
COLUMBUS, Ohio - Mettler-Toledo International Inc. (NYSE: MTD) announced the upcoming retirement of its long-serving Board Chair, Robert F. Spoerry, who will not stand for re-election at the annual meeting of shareholders on May 9th, 2024. Mr. Spoerry, who has been associated with Mettler-Toledo for 40 years, served as the CEO from 1993 to 2007 and as the Chair of the Board of Directors since 1998, shortly after its initial public offering (IPO). As he bids farewell to the company, Roland Diggelmann, an Independent Director of the Board, will be nominated as his successor.
This decision marks the end of an era for Mettler Toledo, as Mr. Spoerry has played a pivotal role in the company s growth and success over the years. As CEO, he led the company through significant milestones and challenges. Under his guidance, Mettler Toledo achieved remarkable financial performance and established its reputation as a leading global provider of precision instruments and services.





Financial Statements
Mettler Toledo International Inc's II. Quarter Investments $ 2,470 Millions MTD's Balance sheet
Mettler Toledo International Inc's II. Quarter Income $ 233 Millions Quarterly MTD's Income Statement
MTD's Income by Division See MTD's Income by Division


MTD Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 2,363 1,968 2,066 2,233 2,118
Y / Y Investment Growth 20.07 % -4.74 % -7.5 % 5.44 % 7.28 %
Net Income in Millions 869 863 789 873 769
Y / Y Net Income Growth 0.7 % 9.43 % -9.6 % 13.46 % 27.58 %
Annual Return On Investment 36.79 % 43.86 % 38.18 % 39.07 % 36.31 %


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 36.79 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MTD's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MTD's Competitors
Subscribers only: Roi for Mettler Toledo International Inc's Suppliers
Subscribers only: Return On Investment for MTD's Customers

Other Ratios
MTD's Roa MTD's Inventory Turnover Ratio MTD's Growth Rates MTD's Dividend Statistics
MTD's Profitability Ratios MTD's Asset Turnover Ratio MTD's Dividend Growth
MTD's Roe MTD's Valuation Ratios MTD's Financial Strength Ratios MTD's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Rigel Pharmaceuticals Inc  89.00 %
Oncotelic Therapeutics Inc   87.35 %
Arbutus Biopharma Corp  85.89 %
Actinium Pharmaceuticals Inc  84.38 %
Exelixis Inc   82.05 %
Lensar Inc   75.31 %
Ironwood Pharmaceuticals inc   70.54 %
Oramed Pharmaceuticals Inc  68.90 %
Indivior Pharmaceuticals Inc   68.79 %
Rallybio Corporation  68.28 %
Fortress Biotech Inc   68.27 %
Earth Science Tech Inc   64.38 %
Meiragtx Holdings Plc  55.83 %
Elite Pharmaceuticals Inc   53.48 %
Idexx Laboratories Inc  51.80 %
Aurinia Pharmaceuticals Inc   50.35 %
Qhslab Inc   48.94 %
Q32 Bio Inc   47.43 %
Vaxart Inc   46.17 %
Liquidia Corporation  42.09 %
Tg Therapeutics Inc   39.26 %
Medpace Holdings Inc   35.54 %
Mettler toledo International Inc   34.41 %
Eli Lilly And Company  33.95 %
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %

Date modified: 2026-09-12T06:18:48+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.